Posted in

Scientist I – Protein Bioanalytical

Scientist I – Protein Bioanalytical

CompanyTessera Therapeutics
LocationCambridge, MA, USA
Salary$Not Provided – $Not Provided
TypeFull-Time
DegreesMaster’s, PhD
Experience LevelEntry Level/New Grad, Junior

Requirements

  • PhD + 0-2 years or MS + 5 years of industry experience in Analytical Chemistry or related discipline e.g., biochemistry, biotechnology or pharmaceutical science. Post-doc experience a plus.
  • In-depth scientific knowledge and hands on technical expertise on LC-MS, LC-MS/MS, and chromatography methodologies and instrumentation.
  • Experience in LC-MS based proteomics is required.
  • Excellent knowledge and hands-on experience in proteomics sample preparation techniques such as immuno-protein/peptide enrichment and fractionation.
  • Extensive experience in protein isolation and purification from in vivo samples, such as biofluid and tissues.
  • Experience in targeted protein quantification with triple quadrupole instrument is a plus.
  • Ability to work in a team orientated environment and conduct multiple laboratory and project tasks efficiently.

Responsibilities

  • Developing LC-MS methods for characterization and quantitation of proteins in various biological matrices including biofluids, tissues, cells, and subcellular fractions.
  • Design and execute proteomics experiments from sample preparation, LC-MS/MS operation to data analysis & interpretation.
  • Establish, optimize, and maintain the workflow of proteomics studies.
  • Discover and validate potential biomarkers for supporting preclinical and clinical programs.
  • Write proteomic reports and contribute to regulatory documents for IND/CTA filings.
  • Providing maintenance, quality control and troubleshooting of high-resolution mass spectrometer and UPLC systems.

Preferred Qualifications

  • Post-doc experience a plus.
  • Experience in method qualification and bioanalyses to support pre-clinical studies from experience working with small molecule LC-MS and bioanalyses for small molecule drugs.